Cencora vs Zoetis

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (77 vs 79)
Cencora logo

Cencora

LeaderHealthcare Tech

Enterprise

Conshohocken PA pharmaceutical distribution (NYSE: COR, formerly AmerisourceBergen) at $316B+ revenue; Retina Consultants of America acquisition $4.4B (Jan 2025) expanding into specialty physician care competing with McKesson.

AI VisibilityBeta
Overall Score
B77
Category Rank
#44 of 596
AI Consensus
88%
Trend
stable
Per Platform
ChatGPT
75
Perplexity
74
Gemini
76

About

Cencora, Inc. (formerly AmerisourceBergen, rebranded August 2023) is a Conshohocken, Pennsylvania-based pharmaceutical distribution and healthcare services company — publicly traded on the New York Stock Exchange (NYSE: COR) as an S&P 500 Health Care component, ranked #10 on the 2024 Fortune 500 and #24 on the Global Fortune 500 — distributing brand-name, generic, and specialty pharmaceuticals, over-the-counter products, and home healthcare supplies to 110,000+ points of care across 11 countries through 46,000+ employees and $316+ billion in annual revenue. Cencora operates as one of the "Big Three" pharmaceutical wholesalers in the United States alongside McKesson and Cardinal Health, collectively supplying approximately 90%+ of the US pharmaceutical supply chain. The company distributes from 26 US pharmaceutical distribution centers and 1,300+ locations across 50+ countries. In January 2025, Cencora completed the acquisition of approximately 85% interest in Retina Consultants of America (RCA) — a leading management services organization for retina specialists — for $4.4 billion, advancing its strategy to expand from pharmaceutical distribution into specialty physician-administered treatments and the high-growth specialty pharmaceutical services market. Founded through the 2001 merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, with predecessor companies tracing to the 1970s, Cencora adopted its current name (meaning "center, core, heart" in multiple languages) in 2023 to signal the brand's evolution beyond commodity distribution.

Full profile
Zoetis logo

Zoetis

LeaderHealthcare Tech

Animal Health

Zoetis (ZTS) reported ~$9.1B revenue in FY2024. World's largest animal health company developing medicines, vaccines, and diagnostics for companion animals and livestock. HQ: Parsippany, NJ.

AI VisibilityBeta
Overall Score
B79
Category Rank
#31 of 596
AI Consensus
66%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
73
Gemini
84

About

Zoetis Inc. is the world's largest animal health company, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, and other technologies for companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish). Spun off from Pfizer in 2013, Zoetis has maintained its position as the global leader in animal health with approximately 300 product lines serving veterinarians, livestock producers, and pet owners in over 100 countries.

Full profile

AI Visibility Head-to-Head

77
Overall Score
79
#44
Category Rank
#31
88
AI Consensus
66
stable
Trend
stable
75
ChatGPT
81
74
Perplexity
73
76
Gemini
84
75
Claude
73
79
Grok
84

Key Details

Category
Enterprise
Animal Health
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Zoetis
Animal Health

Integrations

Only Cencora
Cencora is classified as company. Zoetis is classified as company (part of Pfizer).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.